Gravlee Emily, Pittman Eric, Sparkmon Wesley, Imeri Hyllore, Cox Hannah-Faith, Barnard Marie
School of Pharmacy, University of Mississippi, University, MS 38677, USA.
Pharmacy (Basel). 2021 Oct 13;9(4):167. doi: 10.3390/pharmacy9040167.
After the emergency use authorization of coronavirus disease 2019 (COVID-19) vaccinations in the United States, existing pharmacy infrastructure was leveraged to disseminate vaccines. However, the national uptake of COVID-19 vaccines remains poor. This survey study of Mississippi pharmacists aimed to identify barriers to providing COVID-19 vaccination among pharmacists in practice settings that provided other vaccines. A thematic analysis was used to analyze open-ended survey responses. This study found that the greatest identified barrier to COVID-19 vaccination for pharmacists was patient willingness. The thematic analysis revealed logistical barriers, vaccine hesitancy, and rural pharmacy distribution concerns. These findings suggest that pharmacists require further training in overcoming vaccine hesitancy, and potentially indicate a need for the distribution of vaccination responsibilities to additional pharmacy staff members.
在美国2019冠状病毒病（COVID-19）疫苗获得紧急使用授权后，利用现有的药房基础设施来分发疫苗。然而，COVID-19疫苗的全国接种率仍然很低。这项针对密西西比州药剂师的调查研究旨在确定在提供其他疫苗的实际工作环境中，药剂师在提供COVID-19疫苗接种方面存在的障碍。采用主题分析法对开放式调查回复进行分析。该研究发现，药剂师在COVID-19疫苗接种方面所确定的最大障碍是患者的意愿。主题分析揭示了后勤障碍、疫苗犹豫以及农村药房配送问题。这些发现表明，药剂师在克服疫苗犹豫方面需要进一步培训，并且可能表明需要将接种责任分配给更多药房工作人员。
